ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2518

Behçet’s Disease Immune Landscape Exhibits a Universal NF-kB-mediated Hyperactivation Pattern with Cell-specific TNFAIP3 Responses and a Superimposed IFN-regulated Endotype

Yesim Ozguler1, Olivier Manches2, Didar Ucar3, Ziyan Lin2, Alireza Khodadadi-Jamayran2, Aristotelis Tsirigos2, Gulen Hatemi1 and Johannes Nowatzky4, 1Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey, 2NYU Grossman School of Medicine, New York, NY, 3Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Ophthalmology, Istanbul, Turkey, 4New York University Grossman School of Medicine, New York, NY

Meeting: ACR Convergence 2024

Keywords: Behçet's Syndrome, Inflammasome, innate immunity, interferon, Vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Vasculitis – Non-ANCA-Associated & Related Disorders Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: The immune landscape of Behçet’s disease (BD) remains ill-defined, lacking a unifying picture, precise disease phenotype-endotype correlations, and an understanding of immunity at target tissue sites. Here, we aim to deconstruct peripheral and target organ-specific immunotypes of BD to define their global and endotype-specific applicability.

Methods: We performed single-cell RNA sequencing and multiparametric flow cytometry on anterior chamber fluid cells and PBMC, subjected plasma to Luminex, and functional immune-phenomics studies on human monocytes and monocyte-derived dendritic cells. We included 26 untreated BD and 22 age and sex-matched HD for single cell and an additional 15 SLE control and 11 HD for functional studies.

Results: We observed global NF-kB activation across all myeloid and T cell subsets with enrichment of conventional dendritic cells (cDC) 2 and cDC1 in the eye and increased numerical representation of activated classical and non-classical monocytes in peripheral blood (PB) in BD. TNFAIP3 (A20) upregulation occurred in BD donors versus HD and all myeloid cell types, NK, and NKT cell subsets, but not in canonical T cells. NF-kB or IFN-mediated monocyte activation was not dependent on soluble factors from BD plasma. Plasmacytoid dendritic cells (pDC) were present in the eye during uveitis, and myeloid cells of uveitic BD patients had a superimposed IFN signature with increased numbers of pDC in PB.

Conclusion: NF-kB-dependent activation globally transcends all myeloid and T cell subsets in BD. Myeloid-centric upregulation of TNFAIP3 transcription points to lineage-dependent counter-regulation of inflammatory activity. We also define a superimposed, IFN-dependent activation profile that includes pDC and subsets of myeloid cells and forms a distinct uveitis endotype within BD, providing rationales for disease-wide and endotype and cell type-specific therapeutic targeting.


Disclosures: Y. Ozguler: None; O. Manches: None; D. Ucar: None; Z. Lin: None; A. Khodadadi-Jamayran: None; A. Tsirigos: None; G. Hatemi: Abbvie, 2, AbbVie/Abbott, 6, Boehringer-Ingelheim, 6, Novartis, 6, Pfizer, 2, UCB, 6; J. Nowatzky: Soligenix, 1.

To cite this abstract in AMA style:

Ozguler Y, Manches O, Ucar D, Lin Z, Khodadadi-Jamayran A, Tsirigos A, Hatemi G, Nowatzky J. Behçet’s Disease Immune Landscape Exhibits a Universal NF-kB-mediated Hyperactivation Pattern with Cell-specific TNFAIP3 Responses and a Superimposed IFN-regulated Endotype [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/behcets-disease-immune-landscape-exhibits-a-universal-nf-kb-mediated-hyperactivation-pattern-with-cell-specific-tnfaip3-responses-and-a-superimposed-ifn-regulated-endotype/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/behcets-disease-immune-landscape-exhibits-a-universal-nf-kb-mediated-hyperactivation-pattern-with-cell-specific-tnfaip3-responses-and-a-superimposed-ifn-regulated-endotype/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology